Safety and efficacy of biweekly cetuximab based chemotherapy for patients with metastatic colorectal cancer | Zendy

Jamal Zekri | Zendy; Kamel Farag | Zendy; Rawan Al-Saadi | Zendy; Majed Ashour | Zendy; Rasha Haggag | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Safety and efficacy of biweekly cetuximab based chemotherapy for patients with metastatic colorectal cancer

Author(s) -

Jamal Zekri,

Kamel Farag,

Rawan Al-Saadi,

Majed Ashour,

Rasha Haggag

Publication year - 2016

Publication title -

journal of unexplored medical data

Language(s) - English

Resource type - Journals

ISSN - 2572-8180

DOI - 10.20517/2572-8180.2016.02

Subject(s) - cetuximab , colorectal cancer , medicine , clinical trial , oncology , chemotherapy , medical research , cancer , medical physics , pathology

1College of Medicine, Alfaisal University, 11533 Riyadh, Saudi Arabia. 2Department of Oncology, King Faisal Special Hospital & Research Centre (Jeddah). 21499 Jeddah, Makkah, Saudi Arabia. 3Department of medical oncology, Mansoura University, 35516 Mansoura, Dakahlia Governorate, Egypt. 4Research Centre, King Faisal Special Hospital & Research Centre (Jeddah), 21499 Jeddah, Makkah, Saudi Arabia. 5Department of Radiology, King Faisal Special Hospital & Research Centre (Jeddah), 21499 Jeddah, Makkah, Saudi Arabia. 6Faculty of Medicine, Zagazig University, 44519 Ismailia, Egypt.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research